Skip to main content
MRK logo
MRK
(NYSE)
Merck & Co., Inc.
$130.48-- (--)
Loading... - Market loading

Merck & Co. (MRK) Stock Price & Financial Analysis

Merck & Co. Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$126.62 - $128.83
52-Week High$131.74
52-Week Low$76.66
Open$127.32
Volume7.58M
Average Volume (3M)10.66M
Market Cap315.11B
Shares Outstanding2.47B
P/E Ratio (TTM)35.31
Forward P/E69.48
Price to Sales (P/S)4.80
Price to Book (P/B)6.87
EV/EBITDA19.76
Revenue (TTM)65.69B
Net Income (TTM)8.94B
Free Cash Flow (TTM)14.12B
EPS (TTM)$3.58
Profit Margin13.60%
Operating Margin21.71%
Return on Equity (ROE)19.45%
Debt to Equity1.07
50-Day MA$119.52
200-Day MA$109.50
52-Week Change56.56%
Annual Dividend$3.36
Dividend Yield2.63%
Payout Ratio93.74%
Last Dividend Ex-DateJun 15, 2026

Frequently Asked Questions About Merck & Co.

What is the current stock price for MRK?

As of the latest trading session, MRK stock trades at $127.47. The 52-week range is $76.66–$131.74, with a day range of $126.62–$128.83.

What is the P/E ratio for MRK?

Merck & Co.'s trailing P/E ratio is 35.3, meaning investors pay $35.3 for every $1 of annual earnings. The forward P/E is 69.5, reflecting analyst expectations for future earnings. Merck & Co. operates in the Healthcare sector.

Does MRK pay dividends?

Yes, Merck & Co. pays a 2.63% annual dividend yield ($3.36 per share). The payout ratio is 93.7%. The last ex-dividend date was 2026-06-15.

What do analysts recommend for MRK?

Based on 15 analysts, the consensus for MRK is Buy.

What is the market cap of MRK?

Merck & Co.'s market capitalization is $315.11B, classifying it as a mega-cap company. Merck & Co. operates in the Healthcare sector within the Drug Manufacturers - General industry.